KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Sales

Clover Health Investments (CLOV) Operating Margin (2020 - 2025)

Clover Health Investments (CLOV) has disclosed Operating Margin for 6 consecutive years, with 9.15% as the latest value for Q4 2025.

  • For the quarter ending Q4 2025, Operating Margin rose 1542.0% year-over-year to 9.15%, compared with a TTM value of 0.29% through Dec 2025, up 362.0%, and an annual FY2025 reading of 17.08%, up 2042.0% over the prior year.
  • Operating Margin was 9.15% for Q4 2025 at Clover Health Investments, up from 4.91% in the prior quarter.
  • Across five years, Operating Margin topped out at 9.15% in Q4 2025 and bottomed at 73.29% in Q3 2021.
  • Average Operating Margin over 5 years is 16.33%, with a median of 6.64% recorded in 2024.
  • The sharpest move saw Operating Margin plummeted -7189bps in 2021, then soared 6812bps in 2022.
  • Year by year, Operating Margin stood at 28.49% in 2021, then surged by 58bps to 11.86% in 2022, then increased by 27bps to 8.6% in 2023, then grew by 27bps to 6.27% in 2024, then skyrocketed by 246bps to 9.15% in 2025.
  • Business Quant data shows Operating Margin for CLOV at 9.15% in Q4 2025, 4.91% in Q3 2025, and 2.19% in Q2 2025.